|
PLEKHM1P expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.657300E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.988220E-02 |
| Normal-vs-Stage2 |
1.977970E-01 |
| Normal-vs-Stage3 |
8.297800E-01 |
| Normal-vs-Stage4 |
2.535700E-02 |
| Stage1-vs-Stage2 |
8.364400E-01 |
| Stage1-vs-Stage3 |
5.750300E-02 |
| Stage1-vs-Stage4 |
3.67700000000193E-05 |
| Stage2-vs-Stage3 |
2.475200E-01 |
| Stage2-vs-Stage4 |
1.287810E-02 |
| Stage3-vs-Stage4 |
3.516200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.018200E-03 |
| Normal-vs-AfricanAmerican |
3.514600E-01 |
| Normal-vs-Asian |
3.262400E-01 |
| Caucasian-vs-AfricanAmerican |
1.638790E-01 |
| Caucasian-vs-Asian |
7.880400E-01 |
| AfricanAmerican-vs-Asian |
8.075200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.097900E-03 |
| Normal-vs-Female |
3.582000E-02 |
| Male-vs-Female |
8.310600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.213200E-01 |
| Normal-vs-Extreme_Weight |
8.272000E-02 |
| Normal-vs-Obese |
4.156100E-02 |
| Normal-vs-Extreme_Obese |
6.428800E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.317600E-01 |
| Normal_Weight-vs-Obese |
6.229800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.695000E-01 |
| Extreme_Weight-vs-Obese |
6.093200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.120400E-01 |
| Obese-vs-Extreme_Obese |
6.432400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.710400E-02 |
| Normal-vs-Age(41-60Yrs) |
1.904020E-03 |
| Normal-vs-Age(61-80Yrs) |
3.863600E-02 |
| Normal-vs-Age(81-100Yrs) |
6.791000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.945800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.657600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.196620E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.218600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.838000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.341200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.06859999999365E-05 |
| Normal-VS-Type2 PRCC |
2.119800E-02 |
| Normal-VS-KIRP CIMP |
5.735200E-01 |
| Normal-VS-Unclassified PRCC |
3.336400E-02 |
| Type1 PRCC-VS-Type2 PRCC |
5.38902256153051E-13 |
| Type1 PRCC-VS-KIRP CIMP |
1.116020E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
3.594000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.666200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.647200E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
1.002610E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.367240E-01 |
| Normal-vs-N1 |
7.465600E-01 |
| Normal-vs-N2 |
4.575800E-01 |
| N0-vs-N1 |
1.193570E-01 |
| N0-vs-N2 |
3.879800E-01 |
| N1-vs-N2 |
6.548400E-01 |
|
|
